Michael Kriss, MD
Assistant Professor, Medicine-Gastroenterology

Photo
Medical School:
  • MD, Tufts University School of Medicine (2008)
Undergraduate School:
  • BA, Washington University in Saint Louis (MO) (2003)
Residency:
  • McGaw Medical Center of Northwestern University Program, Chief Resident, Internal Medicine (2012)
Fellowships:
  • University of Colorado, Gastroenterology (2015)
  • University of Colorado, Transplant Hepatology (2016)
Department: Medicine-Gastroenterology

Professional Titles

  • Assistant Professor, Medicine-Gastroenterology
  • Assistant Professor of Medicine
  • Associate Program Director, Transplant Hepatology fellowship
  • UCHealth Transplant Physician Informaticist Champion

Recognition & Awards

  • Advanced/Transplant Hepatology Fellowship Award, AASLD (2015)

Research Interests

My research interests are focused on developing a better understanding of the immune system within the liver. My work focuses on understanding the effects of curing hepatitis C virus on the liver's immune system. In addition, we are studying how the liver responds to bacterial and viral infections to develop a better understanding of how these infections may exacerbate underlying chronic liver disease.

Publications

  • Kriss M, Biggins SW. Evaluation and selection of the liver transplant candidate: updates on a dynamic and evolving process. Curr Opin Organ Transplant. 2021 Feb 1;26(1):52-61. PubMed PMID: 33278150
  • Jackson WE, Kriss MS, Burton JR Jr, Nydam TL, Conzen KD, Pomposelli JJ, Pomfret EA. Reply to "Living liver donation in previous kidney donors: A single-center experience". Am J Transplant. 2021 Jan;21(1):435-437. PubMed PMID: 32558135
  • Burchill MA, Finlon JM, Goldberg AR, Gillen AE, Dahms PA, McMahan RH, Tye A, Winter AB, Reisz JA, Bohrnsen E, Schafer JB, D'Alessandro A, Orlicky DJ, Kriss MS, Rosen HR, McCullough RL, Jirón Tamburini BA. Oxidized Low-Density Lipoprotein Drives Dysfunction of the Liver Lymphatic System. Cell Mol Gastroenterol Hepatol. 2020 Sep 19. [Epub ahead of print] PubMed PMID: 32961356
  • Hughes DL, Rice JD, Burton JR, Jin Y, Peterson RA, Ambardekar AV, Pomposelli JJ, Pomfret EA, Kriss MS. Presence of any degree of coronary artery disease among liver transplant candidates is associated with increased rate of post-transplant major adverse cardiac events. Clin Transplant. 2020 Nov;34(11):e14077. PubMed PMID: 32939833
  • Sherman CB, Said A, Kriss M, Potluri VS, Levitsky J, Reese PP, Shea JA, Serper M. In-Person Outreach and Telemedicine in Liver and Intestinal Transplant: A Survey of National Practices, Impact of Coronavirus Disease 2019, and Areas of Opportunity. Liver Transpl. 2020 Oct;26(10):1354-1358. PubMed PMID: 32772459
  • Kriss M, Golden-Mason L, Kaplan J, Mirshahi F, Setiawan VW, Sanyal AJ, Rosen HR. Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development. PLoS One. 2020;15(7):e0236353. PubMed PMID: 32730345
  • Sundaram V, Mahmud N, Perricone G, Katarey D, Wong RJ, Karvellas CJ, Fortune BE, Rahimi RS, Maddur H, Jou JH, Kriss M, Stein LL, Lee M, Jalan R. Longterm Outcomes of Patients Undergoing Liver Transplantation for Acute-on-Chronic Liver Failure. Liver Transpl. 2020 Dec;26(12):1594-1602. PubMed PMID: 32574423
  • Kolb JM, Conzen K, Wachs M, Crossno J Jr, McMahon B, Abidi MZ, Pomfret EA, Kriss M. Liver Transplantation for Decompensated Cirrhosis Secondary to Telomerase Reverse Transcriptase Mutation. Hepatology. 2020 Jul;72(1):356-358. PubMed PMID: 31943309
  • Turkeltaub J, Kriss M. Management of Portal and Mesenteric Vein Thrombosis. Dig Dis Interv. June 2020;2(4):122-133.
  • Rice J, Hughes D, Burton JR Jr, Pomfret, EA, Pomposelli JJ, Ambardekar AV, Kriss M. Impact of Pre-liver Transplant Cardiovascular Disease Risk Assessment Standardization on Resource Utilization and Recipient Selection. Poster presentation, American Transplant Congress, 5/30/2020.
  • Rosenblatt R, Kriss MS, Patel Y, Seetharam AB, Izzy M, Kapila N, Lopez CR, Nguyen V, Li N, Pereira M, Verna EV. MULTICENTER CONSORTIUM TO INVESTIGATE RISK FACTORS OF INFECTIONS WITH MULTIDRUG RESISTANT ORGANISMS IN LIVER TRANSPLANT RECIPIENTS. Poster Presentation, Young Investigators Award, The Liver Meeting Digital, November 2020.
  • Li N, Rosenblatt R, Patel Y, Kapila N, Izzy M, Lopez CR, Verna EC, Pereira M, Ison M, Angarone M, Seetharam AB, Nguyn V, Kriss MS. MULTICENTER CONSORTIUM TO INVESTIGATE THE INCIDENCE, RISK FACTORS, AND IMPACT OF MULTI-DRUG RESISTANT ORGANISM INFECTION (MDROI) IN LIVING VERSUS DECEASED DONOR LIVER TRANSPLANT RECIPIENTS (LTR). Poster presentation, The Liver Meeting Digital Experience, November 2020.
  • Kapila N, Izzy M, Kriss MS, Li N, Lopez CR, Nguyen V, Pereira M, Seetharam Ab, Verna EC, Rosenblatt R, Patel Y. THE IMPACT OF PRE-LIVER TRANSPLANT MULTIDRUG RESISTANT ORGANISM INFECTIONS ON POST-TRANSPLANT OUTCOMES: ANALYSIS FROM THE AMERICAN LIVER TRANSPLANT RESISTANT ORGANISM CONSORTIUM. Poster presentation, The Liver Meeting Digital Experience, November 2020.
  • Pourmand K, Patel AA, Kriss MS, Schiano TD, Keefer L. BURNOUT AMONG TRANSPLANT HEPATOLOGISTS: A NATIONAL SURVEY. Presidential Poster of Distinction, Oral Presentation, The Liver Meeting Digital Experience, November 2020.
  • Kalra A, Kriss M, Francis P, Norvell JP. CON: Patients of Advanced Age Should Not Routinely Undergo Liver Transplantation. Clin Liver Dis (Hoboken). 2019 Aug;14(2):70-73. PubMed PMID: 31508224
  • Tamburini BAJ, Finlon JM, Gillen AE, Kriss MS, Riemondy KA, Fu R, Schuyler RP, Hesselberth JR, Rosen HR, Burchill MA. Chronic Liver Disease in Humans Causes Expansion and Differentiation of Liver Lymphatic Endothelial Cells. Front Immunol. 2019;10:1036. PubMed PMID: 31156626
  • Kriss M, Verna EC, Rosen HR, Lozupone CA. Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes. Transplantation. 2019 Apr;103(4):668-678. PubMed PMID: 30507741
  • Kriss M, Burchill M. HCV and nonhepatic malignancy: Is pre-emptive direct-acting antiviral therapy indicated prior to treatment?. Hepatology. 2018 Jan;67(1):4-6. PubMed PMID: 28768054
  • Kriss M, Verna EC, Rosen HR, Lozupone CA. Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes. Transplantation. 2018 Nov 30. [Epub ahead of print] PubMed PMID: 30507741
  • Kriss M, Hazleton KZ, Nusbacher NM, Martin CG, Lozupone CA. Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery. Curr Opin Microbiol. 2018 Aug;44:34-40. PubMed PMID: 30036705
  • Golden-Mason L, McMahan RH, Kriss MS, Kilgore AL, Cheng L, Dran RJ, Wieland A, Rosen HR. Early and late changes in natural killer cells in response to ledipasvir/sofosbuvir treatment. Hepatol Commun. 2018 Apr;2(4):364-375. PubMed PMID: 29619416
  • Burchill MA, Roby JA, Crochet N, Wind-Rotolo M, Stone AE, Edwards MG, Dran RJ, Kriss MS, Gale M Jr, Rosen HR. Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy. PLoS One. 2017;12(10):e0186213. PubMed PMID: 29040318
  • Kriss M, Wachs M, Attwell A. An Unusual Cause of Right Upper Quadrant Pain in a Patient With Prior Liver Transplantation for Primary Sclerosing Cholangitis. Gastroenterology. 2016 Mar;150(3):e7-9. PubMed PMID: 26827800
  • Kriss M, Te H, Verna EC, VanWagner LB, Lai JC. Early Career Transplant Hepatologist Compensation, Burnout, and Job Satisfaction Survey. Hep Comm. epub 1/5/2021. https://doi.org/10.1002/hep4.1666
  • Attwell A, Han S, Kriss M. Endoscopic retrograde cholangiopancreatography and liver biopsy in the evaluation of elevated liver function tests after liver transplantation. World J Hep. Accepted 12/4/2020. In press.
View All (25 Total) View Less

Professional Memberships

  • American Association for the Study of Liver Diseases (AASLD), Member
  • American Society of Transplantation (AST), Member

Practice Locations

Hepatology Clinic - Anschutz
1635 Aurora Ct
7th Floor
Aurora, CO 80045
720-848-2280

Hospital Affiliation
  • University of Colorado Hospital

Specialty Information

Specialties
  • Transplant Hepatology, Board Certification (2018)
  • Gastroenterology, Board Certification (2015)
  • Internal Medicine, Board Certification (2011)
Conditions & Treatments
  • Digestive System - Hepatology (Liver Disorders)
  • Digestive System
  • Digestive System - Colonoscopy
  • Surgery - Liver Transplant Surgery
  • Surgery
  • Surgery - Living Liver Donation
Clinical Interests
My clinical interests include providing care to patients with chronic liver disease including evaluation of patients for liver transplantation and providing post-transplant care. In addition, I perform endoscopy (upper GI endoscopy, colonoscopy) and liver biopsies.

Care Philosophy
I provide comprehensive care for liver diseases to my patients. This is done with a multidisciplinary team of hepatologists, surgeons, radiologists, and interventional radiologists to provide the highest quality of care. I focus on patient education and communication with the goal that my patients develop a deep understanding of their medical condition. I also strive to provide personalized care specific to each individual patient's care goals.

Public Speaking
Yes

General Information

Medical Schools:
  • MD, Tufts University School of Medicine (2008)
Undergraduate Schools:
  • BA, Washington University in Saint Louis (MO) (2003)
Residency Programs:
  • McGaw Medical Center of Northwestern University Program, Chief Resident, Internal Medicine (2012)
Fellowships:
  • University of Colorado, Gastroenterology (2015)
  • University of Colorado, Transplant Hepatology (2016)
Department: Medicine-Gastroenterology
;